anti-clotting inhibitor agents
|
Therapy |
|
blocking its inductors including IL-1
|
Therapy |
|
decoy for the recognition and competitive binding to the spike (S) glycoprotein of SARS-CoV-2
|
Therapy |
|
extended lockdown of patients
|
Therapy |
|
immunosuppressive antibody therapy
|
Therapy |
|
inhibition of viral adhesion by exogenous heparin
|
Therapy |
|
Manipulation of heparan sulfate
|
Therapy |
|